Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 0 hours ago • JNJ
2 Dividend Picks Yielding Up To 5.67% For A Balanced Income & Growth PortfolioSeeking Alpha • 1 day ago • JNJ
2025 Dividend Kings: Strong Run ContinuesZacks Investment Research • 1 day ago • JNJ
J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's DiseaseBenzinga • 1 day ago • JNJ
FDA Approves Johnson & Johnson's Tremfya For Crohn's DiseaseReuters • 2 days ago • JNJ
J&J plans to invest more than $55 billion in US over next four yearsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.